What is the outcome of targeted tuberculosis screening based on universal genotyping and location?

American Journal of Respiratory and Critical Care Medicine

Volumn 174, Issue 5, 2006, Pages 599-604

  Moonan, Patrick K ^b   Oppong, Joseph ^b   Sahbazian, Behzad ^b   Singh, Karan P ^b   Sandhu, Raghbir ^b   Drewyer, Gerry ^b   LaFon, Terry ^b   Marruffo, Marco ^b   Quitugua, Teresa N ^b   Wallace, Charles ^b   Weis, Stephen E ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

Genotyping; Location based screening; Mycobacterium tuberculosis

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENE LOCATION; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCREENING; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CARRIER STATE; CLUSTER ANALYSIS; FEMALE; GENOTYPE; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TEXAS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 33748310583     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200512-1977OC     Document Type: Article

References (42)

1. American Thoracic Society. Preventive treatment in tuberculosis: a statement by the Committee on Therapy, American Thoracic Society. Am Rev Respir Dis 1965;91:297-298.
2. Centers for Disease Control and Prevention, Advisory Council for the Elimination of Tuberculosis (ACET). Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Recomm Rep 1999;48(RR-9):1-13.
3. Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States. Washington, D.C.: National Academy Press; 2000.
4. Bass JR. The tuberculin test. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. Vol. 66. New York, NY: Marcel Dekker; 1993. pp. 139-148.
5. Bennett DE, Courval JM, Onorato IM, Agerton T, Daugherty-Gibson JM, McQuillan G, Lewis B, Castro KG. Prevalence of TB infection in the US population, 1999-2000 [abstract]. Annual Meeting of the American Public Health Association. San Francisco, California, November 15-19, 2003.
6. Castro KG, Jaffe HW. Rationale and methods for the National Tuberculosis Genotyping and Surveillance Network. Emerg Infect Dis 2002;8:1188-1191.
7. van Soolingen D, Borgdorff MW, de Haas PE, Sebek MM, Veen J, Dessens M, Kremer K, van Embden JD. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide survey from 1993 through 1997. J Infect Dis 1999;180:726-736.
8. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-1709.
9. Barnes PF, Yang Z, Preston-Martin S, Pogoda JM, Jones BE, Otaya M, Eisenach KD, Knowles L, Harvey S, Cave MD. Patterns of tuberculosis transmission in central Los Angeles. JAMA 1997;278:1159-1163.
10. Bauer J, Yang Z, Poulsen S, Andersen AB. Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex isolates in a country with a low incidence of M. tuberculosis infection. J Clin Microbiol 1998;36:305-308.
11. Solsona J, Cayla JA, Verdu E, Estrada MP, Garcia S, Roca D, Miquel B, Coll P, March F; Cooperative Group for Contact Study of Tuberculosis Patients in Ciutat Vella. Molecular and conventional epidemiology of tuberculosis in an inner city district. Int J Tuberc Lung Dis 2001;5:724-731.
12. Tudo G, Gonzalez J, Gatell JM, Cayla JA, Martinez E, Garcia A, Navarro M, Soriano E, Jimenez de Anta MT; Tuberculosis Investigation Unit of Barcelona, Spain. Detection of unsuspected cases of nosocomial transmission of tuberculosis by use of a molecular typing method. Clin Infect Dis 2001;33:453-459.
13. Solsona J, Cayla JA, Bedia M, Mata C, Claveria J; Grupo de trabajo para estudio de contactos de Ciutat Vella, Barcelona. Diagnostic efficacy of the study of contacts of tuberculosis patients in a high prevalence urban area. Rev Clin Esp 2000;200:412-419.
14. March F, Coll P, Guerrero RA, Busquets E, Cayla JA, Prats G. Predictors of tuberculosis transmission in prisons: an analysis using conventional and molecular methods. AIDS 2000;14:525-535.
15. Moonan PK, Bayona M, Quitugua TN, Oppong J, Dunbar D, Jost KC, Burgess G, Singh KP, Weis SE. Using GIS technology to identify areas of tuberculosis transmission and incidence. Int J Health Geogr 2004;3:23.
16. U.S. Census Bureau. State and County QuickFacts. Available at: http://quickfacts.census.gov/qfd/states/48/48439.html (accessed July 7, 2006).
17. Burgess G. Targeted tuberculosis screening in response to a retrospective analysis of genotyping data and geographic information system data [abstract]. Presented at the Annual Conference of the National Association of County and City Health Officials, St. Paul, MN, July 15, 2004. Available from: http://archive.naccho.org/modelPractices/Result.asp?PracticeID=108 (accessed February 23, 2006).
18. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden JD. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997;35:907-914.
19. Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martin C, Palittapongarnpim P, Plikaytis BB, Riley LW, Yakrus MA, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999;37:2607-2618.
20. Centers for Disease Control and Prevention. Self-study modules on tuberculosis. Atlanta, GA: DHHS, CDC, Division of Tuberculosis Elimination; 1995 (1-5)
21. Self-study modules on tuberculosis. and 1999 (6-9).
22. American Thoracic Society/Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.
23. Monney M, Zellweger JP. Active and passive screening for tuberculosis in Vaud Canton, Switzerland. Swiss Med Wkly 2005;135:469-474.
24. Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, Valway SE, Onorato IM; Contact Investigation Study Group. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002;287:991-995.
25. Moonan PK, Marruffo M, Manguia-Bayona G, Sahbazian B, Bayona M, Burgess G, Weis SE. Tuberculosis: what is the yield of associate investigations in non-BCG-immunized children with positive tuberculin skin tests? Int J Tuberc Lung Dis 2005;9:322-327.
26. Miller TL, Hilsenrath P, Lykens K, McNabb SJ, Moonan PK, Weis SE. Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States. Ann Epidemiol 2006;16:305-312.
27. Kirsch TD, Chanmugam A, Keyl P, Regan LA, Shahan J, Hexter DA, Kelen GD. Feasibility of and emergency department-based tuberculosis counseling and screening program. Acad Emerg Med 1999;6:224-231.
28. Gany FM, Trinh-Shevrin C, Changrani J. Drive-by readings: a creative strategy for tuberculosis control among immigrants. Am J Public Health 2005;95:117-119.
29. Garcia de Olalla PG, Cayla JA, Mila C, Jansa JM, Badosa I, Ferrer A, Ros M, Gomez i Prat J, Armengou JM, Alonso E, et al. Tuberculosis screening among immigrants holding a hunger strike in churches. Int J Tuberc Lung Dis 2003;7:S412-S416.
30. Blumberg HM, Sotir M, Erwin M, Bachman R, Shulman JA. Risk of house staff tuberculin skin test conversion in an area with a high incidence of tuberculosis. Clin Infect Dis 1998;27:826-833.
31. Klaudt K. Mobilizing society against tuberculosis. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. Vol. 144. New York, NY: Marcel Dekker; 2000. pp. 843-863.
32. Ferebee SH, Mount F, Comstock GW. The use of chemotherapy as a prophylactic measure in tuberculosis. Ann N Y Acad Sci 1963;106:151-156.
33. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis 1992;73:73-76.
34. Etkind SC. Contact tracing in tuberculosis. In: Reichman LB, Hersfield ES, editors. Tuberculosis: a comprehensive approach. Lung biology in health and disease. Vol. 66. New York, NY: Marcel Dekker; 1993. pp. 275-289.
35. Weis S. Contact investigations: how do they need to be designed for the 21st century? Am J Respir Crit Care Med 2002;166:1016-1017.
36. Barnes PF, El-Hajj H, Preseton-Martin S, Cave MD, Jones BE, Otaya M, Pogoda J, Eisenach KD. Transmission of tuberculosis among the urban homeless. JAMA 1996;275:305-307.
37. Šebek M. DNA fingerprinting and contact investigation. Int J Tuberc Lung Dis 2000;4:S45-S48.
38. van Soolingen D, Borgdorff MW, de Haas PE, Sebek MM, Veen J, Dessens M, Kremer K, van Embden JD. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide survey from 1993 through 1997. J Infect Dis 1999;180:726-736.
39. Nolan CM. Community-wide implementation of targeted testing for and treatment of latent tuberculosis infection. Clin Infect Dis 1999;29:880-887.
40. Centers for Disease Control and Prevention. New CDC program for rapid genotyping of Mycobacterium tuberculosis isolates. MMWR Morb Mortal Wkly Rep 2005;54:47.
41. Cowan LS, Diem L, Monson T, Wand P, Temporado D, Oemig TV, Crawford JT. Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol 2005;43:688-695.
42. Snow J. On the mode of communication of cholera. London, UK: John Churchill; 1855. Available from: http://www.ph.ucla.edu/epi/snow/snowbook.html (accessed July 7, 2006).